PRMR - ETF AI Analysis
Top Page
PeakShares RMR Prime Equity ETF (PRMR)
PRMR, the PeakShares RMR Prime Equity ETF, has a solid overall rating driven by several high-quality holdings like Walmart and Gilead Sciences, which show strong financial performance, positive earnings sentiment, and strategic growth in areas such as e-commerce and HIV treatments. The fund’s rating is held back somewhat by names like Marriott and Altria, where high leverage, valuation concerns, and market challenges introduce more risk. A key risk factor for PRMR is its exposure to companies with notable financial leverage and sector-specific headwinds, which could increase volatility if conditions worsen.
PRMR vs. SPDR S&P 500 ETF (SPY)
- AUM
- 92.53M
- Region
- North America
- Expense Ratio
- 1.00%
- Beta
- 0.97
- Issuer
- PeakShares
- Inception Date
- Dec 08, 2025
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
PRMR Summary
PeakShares RMR Prime Equity ETF (PRMR) is an actively managed U.S. stock fund that focuses on large, well-established companies rather than tracking a specific index. It invests mostly in American businesses across many sectors, with a strong tilt toward technology and other major industries. Well-known holdings include Microsoft and Meta Platforms, along with companies in energy, health care, and finance. An investor might consider PRMR for growth potential and broad diversification within large U.S. companies. However, because it is heavily invested in stocks—especially tech—it can go up and down significantly with the overall market.
How much will it cost me?
The PeakShares RMR Prime Equity ETF (PRMR) has an expense ratio of 1.05%, which means you’ll pay $10.50 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?
The PeakShares RMR Prime Equity ETF could benefit from strong growth in the technology sector, which makes up a significant portion of its holdings, as well as continued innovation in healthcare companies like Regeneron and Eli Lilly. However, rising interest rates or economic slowdowns could negatively impact financial and consumer cyclical sectors, which are also key components of the ETF. Regulatory changes or geopolitical tensions affecting U.S.-based companies may further influence its performance.
PRMR Top 10 Holdings
PRMR leans heavily into U.S. large-cap growth, with tech names quietly steering the ship. AMD, Dell, and Palantir have been rising, powered by AI and data-center momentum, giving the fund a strong tailwind. Cisco adds a steadier, income-friendly tech anchor, while Walmart and Altria provide defensive ballast when markets wobble. On the flip side, Tesla has been losing steam and TJX looks mixed, both acting as small drags. Overall, the ETF is tech-tilted, U.S.-focused, and driven by a handful of high-octane growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 WMT | Walmart | 2.50% | $2.22M | $1.01T | 23.45% | 78Outperform |
 MCD | McDonald's | 2.49% | $2.21M | $196.75B | -7.34% | 65Neutral |
 LLY | Eli Lilly & Co | 2.43% | $2.16M | $1.28T | 44.44% | 72Outperform |
 MAR | Marriott International | 2.43% | $2.16M | $107.45B | 48.14% | 62Neutral |
 COST | Costco | 2.41% | $2.14M | $472.19B | 14.07% | 72Outperform |
 CME | CME Group | 2.40% | $2.13M | $109.97B | 12.70% | 74Outperform |
 MO | Altria Group | 2.35% | $2.09M | $129.05B | 32.91% | 64Neutral |
 MMM | 3M | 2.30% | $2.04M | $97.03B | 13.00% | 59Neutral |
 PGR | Progressive | 2.28% | $2.02M | $135.10B | 8.66% | 78Outperform |
 GILD | Gilead Sciences | 2.32% | $2.06M | $207.84B | 35.24% | 78Outperform |
PRMR Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRMR, the sentiment is Negative. The current price of 27.32 is below the 20-day moving average (MA) of 28.39, below the 50-day MA of 28.59, and above the 200-day MA of 26.72, indicating a neutral trend. The MACD of -0.25 indicates Positive momentum. The RSI at 34.23 is Neutral, neither overbought nor oversold. The STOCH value of 18.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PRMR.
PRMR Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PRMR | $27.32 | $32.00(17.13% Upside) | $92.53M | 1.00% | 73Outperform |
 FCUS | $32.01 | $39.06(22.02% Upside) | $79.45M | 0.80% | 67Neutral |
 SPCT | $28.17 | $32.11(13.96% Upside) | $73.74M | 0.85% | 72Outperform |
 REGS | $10.59 | $14.54(37.38% Upside) | $68.77M | 0.35% | 74Outperform |
 LCF | $44.78 | $56.41(25.96% Upside) | $70.71M | 0.56% | 73Outperform |
 DEMZ | $46.82 | $58.07(24.01% Upside) | $66.31M | 0.45% | 75Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PRMR | PeakShares RMR Prime Equity ETF | 27.32 | 2.34 | 9.37% | |
| FCUS | Pinnacle Focused Opportunities ETF | 32.01 | -1.65 | -4.90% | |
| SPCT | Liberty One Spectrum ETF | 28.17 | 2.97 | 11.79% | |
| REGS | Columbia Large Cap Growth ETF | 10.59 | 0.50 | 4.96% | |
| LCF | Touchstone US Large Cap Focused ETF | 44.78 | 3.05 | 7.32% | |
| DEMZ | Democratic Large Cap Core ETF | 46.82 | 4.34 | 10.21% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.